Search by Drug Name or NDC

    NDC 68094-0048-61 Guaifenesin Extended-Release 600 mg/1 Details

    Guaifenesin Extended-Release 600 mg/1

    Guaifenesin Extended-Release is a ORAL TABLET, MULTILAYER, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Precision Dose Inc.. The primary component is GUAIFENESIN.

    Product Information

    NDC 68094-0048
    Product ID 68094-048_1361c408-4dfb-47f9-8f81-37eb00b70b2f
    Associated GPIs
    GCN Sequence Number 071885
    GCN Sequence Number Description guaifenesin TAB ER 12H 600 MG ORAL
    HIC3 B3J
    HIC3 Description EXPECTORANTS
    GCN 35905
    HICL Sequence Number 000271
    HICL Sequence Number Description GUAIFENESIN
    Brand/Generic Generic
    Proprietary Name Guaifenesin Extended-Release
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, MULTILAYER, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600
    Active Ingredient Units mg/1
    Substance Name GUAIFENESIN
    Labeler Name Precision Dose Inc.
    Pharmaceutical Class Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078912
    Listing Certified Through 2024-12-31

    Package

    NDC 68094-0048-61 (68094004861)

    NDC Package Code 68094-048-61
    Billing NDC 68094004861
    Package 10 BLISTER PACK in 1 CARTON (68094-048-61) / 10 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK (68094-048-59)
    Marketing Start Date 2023-03-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.32501
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GUAIFENESIN ER 600 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis